title: Assessment of the impact of targeted therapy on metastatic bone disease in renal cancer.
authors.affiliation: Academic Unit of Clinical Oncology, University of Sheffield, Weston Park Hospital, Sheffield, UK. Electronic address: j.e.brown@sheffield.ac.uk.
authors.forename: Janet E
authors.initials: JE
authors.lastname: Brown
authors.affiliation: Cancer Research UK Manchester Institute, The University of Manchester, Withington, Manchester, UK.
authors.forename: Steven L
authors.initials: SL
authors.lastname: Wood
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles